Reagan-Udall Foundation For The Food And Drug Administration, Inc.
Washington, DC
- UEI
- HJLEHGUWDF21
- CAGE
- 8L6X4
- Primary NAICS
- 813212 Voluntary Health Organizations
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 1333 New Hampshire Ave NW #420, Washington, DC 20036, USA
- Website
- reaganudall.org
- Founded
- 2007
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Financials
- Diversified Financials
- Capital Markets
- Fundraising
- SIC code
- 83 Social Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $2,510,454 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $2,510,454 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Is to engage RUF to provide independent stakeholder convening, scientific engagement, operational evaluation, research… | Food and Drug Administration | $2,510,454 |
Grant awards
Similar vendors
About the company
Reagan-Udall Foundation For The Food And Drug Administration, Inc., a tax-exempt nonprofit foundation chartered by Congress, provides independent stakeholder convening, scientific engagement, regulatory science research, and operational evaluation services to the Food and Drug Administration as a prime recipient on cooperative agreements and contracts. The foundation operates exclusively with the FDA and holds no set-aside designations.
RUF's recent award footprint consists of four prime federal grants and contracts, all issued by the FDA's Office of the Commissioner and other centers within HHS/FDA, totaling $2.5 million in combined potential value. The foundation's two active awards anchor its current federal engagement. A $2.5 million firm fixed-price definitive contract awarded September 30, 2026 (running through September 29, 2027) directs RUF to provide independent stakeholder convening and scientific engagement across 16 discrete projects supporting FDA's regulatory science and public health mission, spanning the Center for Devices and Radiological Health, Center for Drug Evaluation and Research, Office of Chief Scientist, Office of Cosmetics and Colors, and Human Foods Program. Project areas include transcranial ultrasound, rare disease diagnostics, medical device real-world evidence, cosmetics adverse events, generic drug quality, food inspection systems, nicotine and alcohol use disorders, and buprenorphine products. Work is performed at RUF's Washington, D.C. facility, virtually, or as specified. RUF executes work under the FDA's Pathways for Regulatory Innovation and Strategic Modernization (PRISM) framework. A larger cooperative agreement awarded June 1, 2026 ($1.3 million) under CFDA 93.103 (FDA Research program) extends through May 31, 2031 and directs the foundation to execute the multi-year PRISM project, advancing FDA priorities through regulatory science tool development emphasizing real-world data and artificial intelligence, programs enhancing access to FDA-regulated products including patient-centered initiatives and controlled substance research, and convenings supporting FDA operations. RUF has completed more than 70 collaborative projects with the FDA between 2020 and 2025. The $2.5 million contract faces recompete in the next twenty-four months as it approaches completion on September 29, 2027.
Quick answers
Is Reagan-Udall Foundation For The Food And Drug Administration, Inc. registered in SAM.gov?
Yes. Reagan-Udall Foundation For The Food And Drug Administration, Inc.'s SAM.gov registration is active through September 22, 2027.
How much has Reagan-Udall Foundation For The Food And Drug Administration, Inc. received in federal contracts?
Federal contracts obligated $2,510,454 to Reagan-Udall Foundation For The Food And Drug Administration, Inc. in fiscal years 2023 through 2027.
What is Reagan-Udall Foundation For The Food And Drug Administration, Inc.'s most recent federal award?
Reagan-Udall Foundation For The Food And Drug Administration, Inc.'s most recent federal contract award is Is to engage RUF to provide independent stakeholder convening, scientific engagement, operational evaluation, research… (75F40126C00214), from Food and Drug Administration, on September 30, 2026.
On GovTribe
See Reagan-Udall Foundation For The Food And Drug Administration, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors